These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 30127448)
1. Selective Elimination of Human Induced Pluripotent Stem Cells Using Medium with High Concentration of L-Alanine. Nagashima T; Shimizu K; Matsumoto R; Honda H Sci Rep; 2018 Aug; 8(1):12427. PubMed ID: 30127448 [TBL] [Abstract][Full Text] [Related]
3. Plasma-activated medium selectively eliminates undifferentiated human induced pluripotent stem cells. Matsumoto R; Shimizu K; Nagashima T; Tanaka H; Mizuno M; Kikkawa F; Hori M; Honda H Regen Ther; 2016 Dec; 5():55-63. PubMed ID: 31245502 [TBL] [Abstract][Full Text] [Related]
4. A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells. Hirai T; Kono K; Sawada R; Kuroda T; Yasuda S; Matsuyama S; Matsuyama A; Koizumi N; Utoguchi N; Mizuguchi H; Sato Y Sci Rep; 2021 Jun; 11(1):11407. PubMed ID: 34075124 [TBL] [Abstract][Full Text] [Related]
5. Signature of circular RNAs in human induced pluripotent stem cells and derived cardiomyocytes. Lei W; Feng T; Fang X; Yu Y; Yang J; Zhao ZA; Liu J; Shen Z; Deng W; Hu S Stem Cell Res Ther; 2018 Mar; 9(1):56. PubMed ID: 29523209 [TBL] [Abstract][Full Text] [Related]
6. A novel in vitro method for detecting undifferentiated human pluripotent stem cells as impurities in cell therapy products using a highly efficient culture system. Tano K; Yasuda S; Kuroda T; Saito H; Umezawa A; Sato Y PLoS One; 2014; 9(10):e110496. PubMed ID: 25347300 [TBL] [Abstract][Full Text] [Related]
7. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts. Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560 [TBL] [Abstract][Full Text] [Related]
8. Electrospun polystyrene scaffolds as a synthetic substrate for xeno-free expansion and differentiation of human induced pluripotent stem cells. Leong MF; Lu HF; Lim TC; Du C; Ma NKL; Wan ACA Acta Biomater; 2016 Dec; 46():266-277. PubMed ID: 27667015 [TBL] [Abstract][Full Text] [Related]
9. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions. Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165 [TBL] [Abstract][Full Text] [Related]
11. Elimination of residual undifferentiated induced pluripotent stem cells (iPSCs) using irradiation for safe clinical applications of iPSC-derived cardiomyocytes. Takeda M; Ito E; Minami K; Harada A; Mochizuki-Oda N; Sawa Y; Miyagawa S Biochem Biophys Res Commun; 2021 Oct; 574():91-96. PubMed ID: 34450429 [TBL] [Abstract][Full Text] [Related]
12. Identification of specific pluripotent stem cell death--inducing small molecules by chemical screening. Conesa C; Doss MX; Antzelevitch C; Sachinidis A; Sancho J; Carrodeguas JA Stem Cell Rev Rep; 2012 Mar; 8(1):116-27. PubMed ID: 21617963 [TBL] [Abstract][Full Text] [Related]
13. Atorvastatin Inhibits the HIF1α-PPAR Axis, Which Is Essential for Maintaining the Function of Human Induced Pluripotent Stem Cells. Nakashima Y; Miyagi-Shiohira C; Noguchi H; Omasa T Mol Ther; 2018 Jul; 26(7):1715-1734. PubMed ID: 29929789 [TBL] [Abstract][Full Text] [Related]
14. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. Burridge PW; Thompson S; Millrod MA; Weinberg S; Yuan X; Peters A; Mahairaki V; Koliatsos VE; Tung L; Zambidis ET PLoS One; 2011 Apr; 6(4):e18293. PubMed ID: 21494607 [TBL] [Abstract][Full Text] [Related]
15. Effect of CDM3 on co-culture of human-induced pluripotent stem cells with Matrigel-covered polycaprolactone to prepare cardiac patches. Dai Y; Zhou F; Zheng J; Mu J; Bo P; You B In Vitro Cell Dev Biol Anim; 2023 Apr; 59(4):256-263. PubMed ID: 37067734 [TBL] [Abstract][Full Text] [Related]
16. Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro. Tanaka A; Woltjen K; Miyake K; Hotta A; Ikeya M; Yamamoto T; Nishino T; Shoji E; Sehara-Fujisawa A; Manabe Y; Fujii N; Hanaoka K; Era T; Yamashita S; Isobe K; Kimura E; Sakurai H PLoS One; 2013; 8(4):e61540. PubMed ID: 23626698 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Four Protocols to Generate Chondrocyte-Like Cells from Human Induced Pluripotent Stem Cells (hiPSCs). Suchorska WM; Augustyniak E; Richter M; Trzeciak T Stem Cell Rev Rep; 2017 Apr; 13(2):299-308. PubMed ID: 27987073 [TBL] [Abstract][Full Text] [Related]
18. Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells. Ben-David U; Nudel N; Benvenisty N Nat Commun; 2013; 4():1992. PubMed ID: 23778593 [TBL] [Abstract][Full Text] [Related]
19. Human induced pluripotent stem cells from two azoospermic patients with Klinefelter syndrome show similar X chromosome inactivation behavior to female pluripotent stem cells. Panula S; Kurek M; Kumar P; Albalushi H; Padrell Sánchez S; Damdimopoulou P; Olofsson JI; Hovatta O; Lanner F; Stukenborg JB Hum Reprod; 2019 Nov; 34(11):2297-2310. PubMed ID: 31743397 [TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of a novel xeno-free culture medium for human-induced pluripotent stem cells. Hua Y; Yoshimochi K; Li J; Takekita K; Shimotsuma M; Li L; Qu X; Zhang J; Sawa Y; Liu L; Miyagawa S Stem Cell Res Ther; 2022 Jun; 13(1):223. PubMed ID: 35658933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]